Genotype-guided dosing of vitamin K antagonists.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation.European journal of clinical pharmacology · 2023
   Article
2. Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations.Clinical pharmacokinetics · 2019
   Article
3. Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?Annual review of pharmacology and toxicology · 2019
   Review
4. Leaving some behind: the growing gap in precision medicine for minority populations.Expert review of precision medicine and drug development · 2019
   Article
5. VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.Medicine · 2016
   Article
6. An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance.Thrombosis and haemostasis · 2016
   Observational
7. Genes affecting warfarin response-interactive or additive?Journal of clinical pharmacology · 2015
   Article
8. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.Pharmacogenetics and genomics · 2015
   Article
9. 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.Personalized medicine
   Article

Corrections and comments

• Commented on by
  Genotype-guided dosing of vitamin K antagonists.2014
• Commented on by
  Genotype-guided dosing of vitamin K antagonists.2014
• Comment on
  A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.2013
• Comment on
  A pharmacogenetic versus a clinical algorithm for warfarin dosing.2013
• Comment on
  A randomized trial of genotype-guided dosing of warfarin.2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as